Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5rzpcl/the_global) has announced the addition of the "The Global Glucose Monitoring Market" report to their offering.

Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, andcomplications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.

The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaks out the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.

There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.

Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market.

A select few are discussed here, including:

  • Abbott Laboratories
  • AgaMatrix Arkray, Inc
  • Bayer Diabetes Bionime Corporation
  • DexCom, Inc.
  • Echo Therapeutics
  • Entra Health Systems LLC
  • Fora Care Inc
  • Genesis Health Technologies
  • GlySure Limited
  • Insulet
  • Johnson & Johnson
  • Medtronic
  • Nipro Diagnostics, Inc
  • Nova Diabetes Care, Inc.
  • Oak Tree International Holdings, Inc
  • Prodigy Diabetes Care, LLC
  • Roche U.S. Diagnostics, Inc.

Key Topics Covered:

  1. Executive Summary
  2. Introduction
  3. Traditional Glucose Monitoring Devices And Diabetes Management Market
  4. Continuous Glucose Monitoring And Sensor Market
  5. Issues And Trends
  6. Global Glucose Monitoring Devices And Diabetes Management Market And Competitor Analysis
  7. Market Analysis By Region
  8. Corporate Profiles

For more information visit http://www.researchandmarkets.com/research/5rzpcl/the_global




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Healthcare and Medical Devices, Glucose Testing, Diabetes Devices

Primary Logo